Treatment
Alzheimer's Disease presents as a complex neurological and psychological condition characterized by cognitive decline and memory loss. While its exact causes remain unkown, but it is characterized by gradual memory loss and decline in cognitive abilities, attributed to the accumulation of amyloid plaques, tau tangles, and reduced acetylcholine levels
Early diagnosis is crucial for effective management and treatment, with brain imaging techniques such as FDG-PET offering promising diagnostic indicators.
While there are no sufficient methods of preventing the disease are available but certain precautions will help in its management and associated factors.
The following table outlines some of the treatments that will slow down the progress of the Alzheimer's Disease.
| Prevention and Management | Lifestyle factors such as regular physical exercise, stress reduction, and healthy diet reduce the risk of Alzheimer disease. |
| Brain Imaging | Structural MRI can detect and monitor hippocampal, regional gray matter, and overall brain atrophy, which are characteristic features of this disease. |
| Genetic Factors | Defective genes may contribute to nerve cell demise in Alzheimer's patients, potentially passed down from parent to child. |
| Therapeutic Agents | Certain drugs can slow down the progression of amnestic MCI in approximately half of Alzheimer's patients for about a year. |
But further analysis are required to perform under controlled trials to assess their results. Acetylcholinesterase inhibitors are the primary medications for Alzheimer's, showing mild enhancements in cognition, behavior, and daily functioning, albeit with unclear clinical significance.
